0001104659-23-085398.txt : 20230728 0001104659-23-085398.hdr.sgml : 20230728 20230728171526 ACCESSION NUMBER: 0001104659-23-085398 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230707 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230728 DATE AS OF CHANGE: 20230728 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NRX Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001719406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 822844431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38302 FILM NUMBER: 231124116 BUSINESS ADDRESS: STREET 1: 1201 ORANGE STREET STREET 2: SUITE 600 CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 484-254-6134 MAIL ADDRESS: STREET 1: 1201 ORANGE STREET STREET 2: SUITE 600 CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Big Rock Partners Acquisition Corp. DATE OF NAME CHANGE: 20171012 8-K 1 tm2317653d9_8k.htm FORM 8-K
0001719406 false 0001719406 2023-07-07 2023-07-07 0001719406 us-gaap:CommonStockMember 2023-07-07 2023-07-07 0001719406 us-gaap:WarrantMember 2023-07-07 2023-07-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT 

PURSUANT TO SECTION 13 OR 15(d) OF THE 

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported) July 7, 2023

 

 NRX PHARMACEUTICALS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-38302   82-2844431
(State or other jurisdiction
of incorporation)		   (Commission
File Number)		   (I.R.S. Employer
Identification No.)

 

1201 Orange Street, Suite 600

Wilmington, Delaware 

   19801
(Address of principal executive offices)   (Zip Code)

 

(484) 254-6134  

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
Common Stock, par value $0.001 per share   NRXP   The Nasdaq Stock Market LLC
Warrants to purchase one share of Common Stock   NRXPW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement. 

 

On July 7, 2023, NRX Pharmaceuticals, Inc. (the “Company”) entered into Amendment #2 to Convertible Promissory Note (the “Second Amendment”), with Streeterville Capital, LLC (the “Streeterville”). Pursuant to the Second Amendment, the Company and Streeterville agreed to further amend the terms of that certain convertible promissory note dated November 4, 2022 in the original principal amount of $11,020,000 (the “Original Note”), as amended by Amendment to Convertible Promissory Note dated March 30, 2023 (as amended, the “Note”). In accordance with the Second Amendment, the Company and Streeterville agreed to amend the redemption provisions of the Note. In particular, the Company agreed to pay Streeterville an amount in cash equal to $1,800,000 on or before July 10, 2023, which amount was paid on July 10, 2023. In addition, beginning on or before July 31, 2023, on or before the last day of each month until December 31, 2023 (the “Minimum Payment Period”), the Company shall pay Streeterville an amount equal to $400,000 in cash (a “Minimum Payment”), less any amount satisfied by the delivery of Redemption Conversion Shares (as defined and discussed below). Notwithstanding the foregoing, Streeterville may also submit a request for redemption of up to an aggregate of $1,000,000 per month (the “Maximum Monthly Redemption Amount” and, together with the Minimum Payment Amount, the “Redemption Amounts”) in accordance with the terms of the Note. However, the portion of each Minimum Payment that is not satisfied by the delivery of Redemption Conversion Shares is the maximum amount of cash the Company will be required to pay in accordance with the Second Amendment during the Minimum Payment Period. The redemption of the Maximum Monthly Redemption Amount in excess of the Minimum Amount may be satisfied by the delivery of additional Redemption Conversion Shares.

 

During the Minimum Payment Period, the Company is permitted to pay the Redemption Amounts in the form of shares of common stock of the Company (the “Redemption Conversion Shares”) calculated on the basis of the Redemption Conversion Price (as defined in the Note) without regard to the existence of an Equity Conditions Failure. Moreover, the Redemption Premium (as defined in the Note) will continue to apply to the Redemption Amounts.

 

The foregoing description of the Second Amendment does not purport to be complete and is qualified in its entirety by the full text of the Second Amendment attached hereto as Exhibit 10.1.

 

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

On July 20, 2023, the Company received a written notification (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5450(b)(2)(A) – Market Value of Listed Securities (“MVLS”) because the Company has not maintained a minimum MVLS of $50,000,000 for the last thirty-three (33) consecutive business days.

 

Nasdaq’s Notice has no immediate effect on the listing of the common stock on The Nasdaq Global Market and, at this time, the common stock will continue to trade on The Nasdaq Global Market under the symbol “NRXP”.

 

Pursuant to Nasdaq Listing Rule 5810(c)(3)(C), the Company has been provided an initial compliance period of 180 calendar days, or until January 22, 2024, to regain compliance with the MVLS requirement. To regain compliance, the Company’s MVLS must meet or exceed $50,000,000 for a minimum period of ten consecutive business days prior to January 22, 2024.

 

If the Company does not regain compliance within the allotted compliance period Nasdaq will provide notice that the Company’s shares of common stock will be subject to delisting and may potentially be traded on the Over-the-Counter market thereafter.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit
No.

Description

10.1 Second Amendment to Convertible Promissory Note, dated July 7, 2023, by and between NRx Pharmaceuticals, Inc. and Streetervillle Capital LLC.
104 Cover Page Interactive Data File (embedded within Inline XBRL document)

 

2 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  NRX Pharmaceuticals, Inc.
   
Date:     July 28, 2023 /s/ Stephen Willard
  Stephen Willard
  Acting General Counsel

 

3 

 

 EX-10.1 2 tm2317653d9_10-1.htm EXHIBIT 10.1

 

Exhibit 10.1

 

AMENDMENT #2 TO CONVERTIBLE PROMISSORY NOTE

 

This Amendment #2 to Convertible Promissory Note (this “Amendment”) is entered into as of July 7, 2023, by and between Streeterville Capital, LLC, a Utah limited liability company (“Lender”), and NRX Pharmaceuticals, Inc., a Delaware corporation (“Borrower”). Capitalized terms used in this Amendment without definition shall have the meanings given to them in the Note (as defined below) and Amendment #1 (as defined below).

 

A.           Borrower previously issued to Lender that certain Convertible Promissory Note dated November 4, 2022 in the principal amount of $11,020,000.00 (the “Note”).

 

B.            Pursuant to that certain Amendment to Convertible Promissory Note dated March 30, 2023 (“Amendment #1,” and together with this Amendment, the “Amendments”), Borrower and Lender amended the Note to address ownership limitation issues.

 

C.            Lender and Borrower have agreed, subject to the terms, conditions and understandings expressed in this Amendment, to amend the Note and Amendment #1.

 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:

 

1.            Recitals. Each of the parties hereto acknowledges and agrees that the recitals set forth above in this Amendment are true and accurate and are hereby incorporated into and made a part of this Amendment.

 

2.            Cash Payment. Notwithstanding the terms and conditions of the Note and Amendment #1, Borrower covenants and agrees to pay to Lender an amount in cash equal to $1,800,000.00 on or before July 10, 2023. Borrower shall make such payment to Lender via wire to an account designated in writing by Lender.

 

3.            Equity Conditions. Notwithstanding the terms and conditions of the Note and Amendment #1, Lender agrees that from the date hereof until December 31, 2023, Borrower may pay any Redemption Amount via a Redemption Conversion, even if an Equity Conditions Failure exists.

 

4.            Minimum Debt Service Payment; Maximum Monthly Redemption Amount; Waiver. Notwithstanding the terms and conditions of the Note and Amendment #1, Borrower shall, beginning on or before July 31, 2023, and on or before the last day of each month thereafter until December 31, 2023 (the “Minimum Payment Period”), pay to Lender an amount equal to $400,000.00 in cash, less any Redemption Amount satisfied in Redemption Conversion Shares for such month (each, a “Minimum Payment”). For any portion of a Redemption Amount to be deemed satisfied in Redemption Conversion Shares, such shares must have been deposited and cleared for resale in Lender’s brokerage account. For the avoidance of doubt, (i) Borrower shall make six (6) separate Minimum Payments to Lender in the amount of $400,000.00 under this Section 4 during the Minimum Payment Period, (ii) that portion of each Minimum Payment that is not satisfied in Redemption Conversion Shares is the maximum amount of cash Borrower shall be required to pay in fulfillment of its obligations under this Section 4, and (iii) Lender may still submit Redemption Notices during the Minimum Payment Period for any Redemption Amount, up to the Maximum Monthly Redemption Amount, in excess of the Minimum Payment, which amount Borrower may satisfy in Redemption Conversion Shares. Moreover, Lender hereby waives the application of the Trigger Effect and any of the other remedies set forth in Section 4 of the Note, including without limitation any Default Interest or other fees and expenses applicable to Trigger Events or Events of Default that may have heretofore occurred (the “Waiver”). Notwithstanding the foregoing, the Waiver shall not apply to any Trigger Events or Events of Default occurring after the date of this Amendment.

 

 

 

 

5.            Redemption Premium. For the avoidance of doubt, all Minimum Payments and any other payment of any Redemption Amount in cash, including the required cash payment set forth in Section 2 hereof, shall be subject to the Redemption Premium.

 

6.            Representations and Warranties. In order to induce Lender to enter into this Amendment, Borrower, for itself, and for its affiliates, successors and assigns, hereby acknowledges, represents, warrants and agrees as follows:

 

(a)            Borrower has full power and authority to enter into this Amendment and to incur and perform all obligations and covenants contained herein, all of which have been duly authorized by all proper and necessary action. No consent, approval, filing or registration with or notice to any governmental authority is required as a condition to the validity of this Amendment or the performance of any of the obligations of Borrower hereunder.

 

(b)            There is no fact known to Borrower or which should be known to Borrower which Borrower has not disclosed to Lender on or prior to the date of this Amendment which would or could reasonably be expected to materially and adversely affect the understanding of Lender expressed in this Amendment or any representation, warranty, or recital contained in this Amendment.

 

(c)            Except as expressly set forth in this Amendment, Borrower acknowledges and agrees that neither the execution and delivery of this Amendment nor any of the terms, provisions, covenants, or agreements contained in this Amendment shall in any manner release, impair, lessen, modify, waive, or otherwise affect the liability and obligations of Borrower under the Note or any other transaction documents entered into in connection with the Note (the “Transaction Documents”).

 

(d)            Borrower has no defenses, affirmative or otherwise, rights of setoff, rights of recoupment, claims, counterclaims, actions or causes of action of any kind or nature whatsoever against Lender, directly or indirectly, arising out of, based upon, or in any manner connected with, the transactions contemplated hereby, whether known or unknown, which occurred, existed, was taken, permitted, or begun prior to the execution of this Amendment and occurred, existed, was taken, permitted or begun in accordance with, pursuant to, or by virtue of any of the terms or conditions of the Transaction Documents. To the extent any such defenses, affirmative or otherwise, rights of setoff, rights of recoupment, claims, counterclaims, actions or causes of action exist or existed, such defenses, rights, claims, counterclaims, actions and causes of action are hereby waived, discharged and released. Borrower hereby acknowledges and agrees that the execution of this Amendment by Lender shall not constitute an acknowledgment of or admission by Lender of the existence of any claims or of liability for any matter or precedent upon which any claim or liability may be asserted.

 

2

 

 

(e)            Each of Borrower and Lender represents and warrants that as of the date hereof no Events of Default or other material breaches exist under the Transaction Documents or Amendment #1 or have occurred prior to the date hereof.

 

7.            Certain Acknowledgments. Each of the parties acknowledges and agrees that no property or cash consideration of any kind whatsoever has been or shall be given by Lender to Borrower in connection with this Amendment.

 

8.            Other Terms Unchanged. The Note and Amendment #1, as amended by this Amendment, remain and continue in full force and effect, constitute legal, valid, and binding obligations of each of the parties, and are in all respects agreed to, ratified, and confirmed. Any reference to the Note after the date of this Amendment is deemed to be a reference to the Note and Amendment #1 as amended by this Amendment. If there is a conflict between the terms of this Amendment and the Note or Amendment #1, the terms of this Amendment shall control. Except as otherwise set forth herein, no forbearance or waiver may be implied by this Amendment. Except as expressly set forth herein, the execution, delivery, and performance of this Amendment shall not operate as a waiver of, or as an amendment to, any right, power, or remedy of Lender under the Note or Amendment #1, as in effect prior to the date hereof. For the avoidance of doubt, this Amendment shall be subject to the governing law, venue, and Arbitration Provisions, as set forth in the Note.

 

9.            No Reliance. Borrower acknowledges and agrees that neither Lender nor any of its officers, directors, members, managers, equity holders, representatives or agents has made any representations or warranties to Borrower or any of its agents, representatives, officers, directors, or employees except as expressly set forth in this Amendment and the Transaction Documents and, in making its decision to enter into the transactions contemplated by this Amendment, Borrower is not relying on any representation, warranty, covenant or promise of Lender or its officers, directors, members, managers, equity holders, agents or representatives other than as set forth in this Amendment.

 

10.            Counterparts. This Amendment may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one instrument. The parties hereto confirm that any electronic copy of another party’s executed counterpart of this Amendment (or such party’s signature page thereof) will be deemed to be an executed original thereof.

 

11.            Further Assurances. Each party shall do and perform or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request in order to carry out the intent and accomplish the purposes of this Amendment and the consummation of the transactions contemplated hereby.

 

[Remainder of page intentionally left blank]

 

3

 

 

IN WITNESS WHEREOF, the undersigned have executed this Amendment as of the date set forth above.

 

  LENDER:
   
  Streeterville Capital, LLC
   
  By:  
    John M. Fife, President
   
  BORROWER:
   
  NRX Pharmaceuticals, Inc.
   
  By:                            
    Stephen Willard, CEO

 

[Signature Page to Amendment #2 to Convertible Promissory Note]

 

 

 EX-101.SCH 3 nrxp-20230707.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 nrxp-20230707_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 nrxp-20230707_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Class of Stock [Axis] Common Stock [Member] Warrant [Member] Statement [Table] Document Information [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 nrxp-20230707_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover
Jul. 07, 2023
Document Information [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jul. 07, 2023
Entity File Number 001-38302
Entity Registrant Name NRX PHARMACEUTICALS, INC.
Entity Central Index Key 0001719406
Entity Tax Identification Number 82-2844431
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 1201 Orange Street
Entity Address, Address Line Two Suite 600
Entity Address, City or Town Wilmington
Entity Address, State or Province DE
Entity Address, Postal Zip Code 19801
City Area Code 484
Local Phone Number 254-6134
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Common Stock [Member]  
Document Information [Line Items]  
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol NRXP
Security Exchange Name NASDAQ
Warrant [Member]  
Document Information [Line Items]  
Title of 12(b) Security Warrants to purchase one share of Common Stock
Trading Symbol NRXPW
Security Exchange Name NASDAQ
XML 8 tm2317653d9_8k_htm.xml IDEA: XBRL DOCUMENT 0001719406 2023-07-07 2023-07-07 0001719406 us-gaap:CommonStockMember 2023-07-07 2023-07-07 0001719406 us-gaap:WarrantMember 2023-07-07 2023-07-07 iso4217:USD shares iso4217:USD shares 0001719406 false 8-K 2023-07-07 NRX PHARMACEUTICALS, INC. DE 001-38302 82-2844431 1201 Orange Street Suite 600 Wilmington DE 19801 484 254-6134 false false false false Common Stock, par value $0.001 per share NRXP NASDAQ Warrants to purchase one share of Common Stock NRXPW NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 3 23 1 false 2 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://nrx.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2317653d9_8k.htm nrxp-20230707.xsd nrxp-20230707_def.xml nrxp-20230707_lab.xml nrxp-20230707_pre.xml tm2317653d9_10-1.htm http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm2317653d9_8k.htm": { "axisCustom": 0, "axisStandard": 1, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 26 }, "contextCount": 3, "dts": { "definitionLink": { "local": [ "nrxp-20230707_def.xml" ] }, "inline": { "local": [ "tm2317653d9_8k.htm" ] }, "labelLink": { "local": [ "nrxp-20230707_lab.xml" ] }, "presentationLink": { "local": [ "nrxp-20230707_pre.xml" ] }, "schema": { "local": [ "nrxp-20230707.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 65, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 2, "nsprefix": "nrxp", "nsuri": "http://nrx.com/20230707", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2317653d9_8k.htm", "contextRef": "AsOf2023-07-07", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://nrx.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2317653d9_8k.htm", "contextRef": "AsOf2023-07-07", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://nrx.com/role/Cover" ], "xbrltype": "domainItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0001104659-23-085398-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-23-085398-xbrl.zip M4$L#!!0 ( .V)_%8=O^WP/0, 0- 1 ;G)X<"TR,#(S,#],_T'U:\878&@*@6124CI,2=.!YM*\=(0MB":RY$IR[.3K M*]F6N1@(T,9/TNXY9W>EE>3.61H2\(2XP(QVK9KC60!1GP68SKK6]=@^'_<& M PN"R.")%*./%(;-)U:"P+;WD'W!M& \>O1H-1]D#(2;==-DL2A[ DFC#\* MQV?A;H)C"64L2C4O]8IO-_HE%GY)/H+GS>0X'>&[&:*?XB%LW/NW$ ^/)E?! MR_WHJ/?K,97AY^;D/OSV\IR(1M\-;WI>S#"K?[E-SO.0'>$_H! "M1E4="U= M7U%>TG 8G[EUSZNY=Y?#<8:SUK1ND:PFL M;TNKL#UP-.U:ND=LLY6_5=F.ZAT#T1&VG-5LCU97J@AL)"#W*RJ5NT2)L AQ MB57K+UP8>>I8:OJ/A3! QQ$6OFXXJG'$):.7*VO;,Y _DD/F9U!:*GMF&9VN37:NK MV]9)13#/=)\DYLNP7Q*&=T 2&QZ[=?'%)K@>9,VT:] -C^;6H&LY+B)2&,O! M*2P^L?^00R:S5Q*OO]N;TGF-F&ULU5U=4R.Y%7U/5?Y#QWDVMF'9 M">R0+<8#6ZZ=&0AF9Y*\4'*W;*M02RY)#?:_C]0?IC]TN]L)B(@'L-OW2N>> MHY9T6Y+Y^.LVIL$3%I)P=C&8'(T' 68ACPA;70S^F \OY]/9;!!(A5B$*&?X M8L#XX->___E/@?[Y^)?A,+@FF$;GP6<>#F=LR7\)OJ$8GP>_888%4ES\$GQ' M-#%7^#6A6 13'F\H5EA_D%5\'IP>3=ROP+E"*I'[TL;;FU\+)'&@^6+R?"O) MQ<#4FU?[?'+$Q6IT/!Y/1O_\^F4>KG&,AH09WD(\*+Q,*3:_R=G9V2C]M#!M M6&X7@A9UG(P*./N2]:>1VCN4C4]'V8=E4])2= FT).0+#Y%*6T@GH@"T M,.^&A=G07!I.CH!^:N%WM?*Q-;(.C+71U.NFZT& MF7JL!5[JEBFV&UWP\!A1&+,3$L?!'E%Y;#VI1"F1MITE-N,K 6\/>Y]9<.( MQX@<"+KI[0!Q6M,PQO'"R'T0W*KKVV-%E!Z&,'5X>UR,J\M#H14^3MLD7J*$ MJO^Z41;N5LC!48'<%-BC2U)$&;M\+)D$0S/P)!J& MTB\SRQQ!@8'RL%(Q-;TN%TW&9!&JQ.'1BC^-(DQ&IM\S+](.,.,,DX>B3C/@ MB1CE >*9PK$L"J9H@6E:W8-V:?<8_<^8ET@N4HT2.5PAM,F 8ZID<>4E@OS" M@QFBL0%UCQ8O3:B$.S>LV]71OJA\*0K<>1/I>1]F[?(\Y$SI=G%%T]ITV\8K M\Z) MA0\[DEH3AYOC:/,L(8S"+B(L-#SM?$+(LHECBX&2B26P!W+-*5(RIOE M7/'P\7)+;"VM'FG3Y57%LPZE=;':V0NI0A?LX'94@0F^VK*M&< M'W3) #+,.Y%#4AR/_=3B86(!_EIR%"/CH7W+[SQ?O=8GM\T-C\?"38X(/G$[9X$(,OTKWTDWPI083&4#7%*WL#%=,/*"X MB?=-9T ',/:+? MAAQ2X-3Q9$9/LF1*6!\)ZM8>:6"%#HGPLUL1YFM,J5GZ0ZS7G="T]T@( #PD MQ8?WD^+JR4PC]'C57XV]BZ>"5/%#FOS-K2:W6! >Z9F#Z*%&S=@C'6S((07. MWD.!*Q;UY3\W]8[],NZVE067Y%\3&2*:X;O6USH6IQKF'HE@Q_ZV3]P.%>)? M&(G>,NR-O1.ABAR4P%'V/$V$J$!K[8L@:P]$:(4.JN H7[YBBJB=V:GV+0&> M-6NSNI4'K%LA@VP[2I(S4,7#$Z;,EKPVQJN6WK!N@0TR[R@YSH!-=20"T1F+ M\/9WO&NCOF;J#?)8S+V1!,(.+K8YRITA=,>'"7'LL1#' M[4(XRITA=">'"7'BL1 G[4(XRJ KZ*;ZY8VXY\_ VC]@[)L(->2@!$[3YQQ; M.G[=B%O!GTAVI*A+AYJ';V+8X(.*.$VQB]:232;ZW!&9I6\*E&&#S#M-L7-@ MMUPJ1/]--EWS6)N];RHTP8-:.,JX\W9A'L1 F\$J)AXPWL0+DNPHK39CT:7 M"&[B90L?**[#!1EVE"-_X6;M:,U9Z]/INI4'3%LA@VR[2G7-T3\)=AC[CSW@ MMXH5(O9U#EET$_M#$*7QF,,'"X',M_W,=_&"4_A0DL70 \XAU"#MCK+1"BH[X143#ZANX@5)=I2- M%C?8=9:DO7=VJ5Q^^\J\/7_7HPQUEJ06H[*"! MO@=O%I2L$'SJL<7!(PT@]) 0H[L'%HIF&O]PBZ$U=0#"6#<(/FNCOXF M$5$XR@!>$X98J%/ _8%,X!E#EY/O^A8JA-_PW48.T.]TC/8\1I9\2J0.0K3U2Q= ;VINH0=J=[H*^BK%8 MZ8[Q-\&?U3H_N-Q&O]7!&QE@]* <3G<[7VU?OEHA.[G9JD7#VA\A[- A%4X= M'Q.^#$.SZ26;,; ("4 'V-X#)3K @UHX2K%OU!J+\LPMA6:":=N2TN7E@2Z] M0@#5<9IBE[_NHG70+MEYH &N3<:09]FRPH":\I1ZUY0LG,&\;KF$'"G6;- MGQ![%,E&A;M;P4.,S?*3W-^?/5*V7@5X(U+_:$#YW!X]?OGFV?D:"2QO$I7^ MGQF-MO711XN?-V)U!@%JY/AKN^3+@40[ M!XH=%@LH7"EM_SBJA:FK?]2?Y=?-+_-/DYU$/Q9Y*2Q:,/OV[7&7HB/$\9/1GM[[T?(4(3MDCIZF3T93H^ MG9Y=7HY07F"ZP!FCY&1$V>C77_[X!R3^?/C3>(PN4I(MCM$GEHPOZ9+]C*[Q MFARCWP@E'!>,_XR^XFPCM["+-",4^Y70 M!>-?[B[KGY_W*'O"SXP_Y'L)6P\K<%K@8I/7I;W?OB__Z/ / M64H?CN5?7HRDL4O(J(J2I;CB]H^.CB9J;R6UE-LYSZIC'$XJ.W7)8F_:H6\XR=/C7-F[8@DN M5+/W'@:!"OF_<24;RTWC_8/QX?[>-E^,JI.OSB!G&;DC2Z2J>5R\/ J4\E22 M,"JWW7.R=)O).)_(^ DE*UR0A3S0D3S0_M_D@?Y<;K["$IZRQ3E]FVLS.I!]\=WAQ7]1@6:\]RK,6(&S-YEO1GJW?4W>=L9W M6!U! M#0QEV77I+&F5F\G>G'&[[G)D5&4N<3Y7!6_R\0KC1W& @\,)R8J\VC*66]1) M*#?\D&,C61-:G&4XSV^6TX(E#Z?;-*^.HRIY,AJ@GY@5D)&GO*H%YDG/J2@5 MDX2)@>RQ&&?ZI.OP)6?K03;*<\8&B']D\[I\?9*%!: B+1DG.=OPA+RJC9NU M&7I62X?K3$3("1NAXR_3T2]*AM@2*2'Z+J7__C#9%1V$)3'M6S.J+'TFZSGA M0&T=.I_L@#:;S%BB:%B!G%F,*%U%B):&9^0;YAS3HI,/0^.3#:>])A%"H.[T9GN_&=*AG+$5!!IF60>?(HA31X."T9?)0B]!W)?O? I&3 M9&_%GB8+DFH6Q(<= N(_/\15^D8>7EZI\[6Z4!5S*7(I3)F3CWZY#RR&FI: M]&F#HS+0H E-%8(:,>B[C$(J+!1$,U%B1PWU;M^0-$V94,A]44'0, 0VNM1X M;N!3<>"%//A%AE<.^\9^7TWLM%6U<6MG%(WLL71T8X#>=]??:=L< M"YSB** 9XA <+9I!J(X*Q-$II1N2&RI M]\L-P*QUZ6'HHN($, =?DM3ZL*1,[TF6R><>,.WO4%QBW[3 ADU>;&54Q(#V M0&94!"I#XL'F_$G.SL4T:6!E&_J0\%BVN_BIQ=$B9#H<2)$*0S(N$$F-QRUZ M&+*4OND!K)K<&+*HB'%[ UG1L7&(?6-R"@71,22Q@5*) [$!8=4#&C0H("\T^"^3!< M&LHPL%A6W:C4L@A!,;WU82+U02 YVW#><@V/.+#4%R9]9BM.(%T4H/28LYX- MTO(6*(%&H'-:I,6+7#=PO7$\$^26^&(#,EZ/@@7 E,F EB&I0UH8I.6K M7PEH(1=K@-4Q97X)<)ML4]#61$2"TQA PTZKULX$(>),]$P<9Y=T0;:_DQ>P M7I;.+Q. S384AB@B*MS. "Q*,5)J).1!P+CEZ1KSEVF:] P5MM O&I#1-ANF M*B(X &L ':4:32_/0HXD,[R]7 A0TV6JU[WU4 +J_<+28[O-#"".")UNAP!! M(@BUHT*"=$D3QA]9XW&',[81'>#+&5O ,Y2>*+]0#:I"&ZW.D(@ &^(3P*P5 M^DX_DX*87*^L"D"RA"#$G2X6XD3EY3]7*27[8/V=6K]T==AM,^401D02[ [@ MIU2^JSX@&8-N:"S0'+RBJ@?AH3D8"LU!U- W8]G TJ@R!C6W4"LY/%AXOEK0\6&2#G,S(D M)"9J8G7#;SE[2FD"3YDA>1!@ --.:@QM?.BX#?;Q4T^(J[B@?8V>E/=^22I9 MF%ZF;=+=Q6A-?)"TC?5V+EH=$HE;EAH3V;F^-[#!5MW%C7QQ-;!NR6EA]KX4FQ!=99K'+;N\9A1\0L"6^6AHR M5[6VN3^*%@=,F:VN9$CI MV-EYFT;4CBM8UW5C#=+7? MKE3MM5BWN%$71^EW.K(Q 6HO:8L]83%F6 M)FF1TM5GG<$F]C$F"N'I&, M_5&P 9@R65#[9&[3_8._S/^*JBC/S7_-9AS+)/G3E_6<94#V*:?*%P0=%BL. M')(H4(!]F31<,U1*D=:&R$[5,NNHCK'?%P!.6U73MW9&T>@N1]:7O]76@;K\ M\VUR+TP18$&"6^:[ZW>9-+O_IB8*!#J,61T5"G.&FER+\0'1RT!G;>G1Q\'0,),63CJLRF58 M!^Y27?J^E:X?P/A&LNQWRI[IE."<4;+0]U)B9 YY<%\3?A*#&^_?EZW:;F>!U.:'>-)(D8NA+K$WM\Z M AJVWCUB*:, J=<>_!Z2.@)5(9ZIN1$,\^9UG#(AWZ4'KG;H#_%%T%#S%4=] M^BAH&FC29$J%M2^N5:!Z+V+(;$;-Y/;P%*\E\CPS=A@T)L8-112,@+:@:7'S M70%AT:RO)T@(@)L5U"*/"5$2AFD_3]B^L W MCT7RZN^^V\#H_TR\ZHJM6D:%!H19Z_Q"Q"X*P(URGC7&+%" MWLQKO-1^>H_%";S9%+D<084Q^"YX9Y#GGQ<&5,#XD:$C(B+T!MB$?G!0D4B% MOD,ZB UV?Y;LL@&3Q\>6.+ F7ZPYF9%M\% =ZZ+C"&!#K^^IM<'7,B[G> MP"@@?*U;Z%(O1\T"T%P^(U86@;[+0I JQ?7^\N:F*_%);*XVB;_F."=BRW\ M4$L#!!0 ( .V)_%8PEAEC(P@ #MD 5 ;G)X<"TR,#(S,#&ULU5U15]LV&'W?.?L/7O86_-F2.7V[G-'H$0M).#MK]0ZZK0BS MF">$38X8%4ER\B;X@FIHC_(I0+*(^G\TI5EA_D3=\$KTZZ!VC MJ-T&U/L%LX2+SW>#3;U3I>;RI--9+!8'C#^B!1U=9?= M];^\^"DE[.'$_!@AB2.M%Y,G2TG.6J;==;.+HP,N)IW#;K?7^?/C]3">XAEJ M$V9TBW&K*&5JJ2K7.SX^[F3?%M 21^5^[MVF5B:7Q MJF..=_I<]T4=9%9B*O!8=S>QG.N*#X^ZK[NO3;4_[X#4:J[[I"2F2[6BSDZ3 M:T/[!3!2Z5[$DZ*BDS[@* 440:W[B*]J&WZ4SK3S>B/.7(=0Q$% MY?%.P]3HSO=8%GTX4U?B^&#"'SL))AW#W'S(),CHZU^^90V=CZ02*%9%312- M,,WJ_Z8Q>Y#.=T1X:IDH61YYB7!_X9LXM;,2Y1R/C3RG0 M-7 ?MQ_MMI/G8C=R).*B8OUQQ\9R?UTC.G,D='WM>$KHI@>,!9_9Y%LWR)U1 MIM8*(\K0.A\VI_]_Y("]'^U+;Z.YU4?\ M&/ 5"8&8JA-_#P84_LB[\)7T7E1T^,Q\KVMTS\0Y BCNBVM;.YM:)]]M9@V+ M>Z[;3TP,5Q1-JM7=@P#E[06@;R4Y7P*_PS(69&YBKM%Y!^EMC/X.N2NH>AHS M[O"$F+3#A+*9[]V#B*6(MR'[WP\K3O*>##EG+$7T#L^YJ/%A%PF4_Y> Y*^B MZDGU/U(D%!9T!1&^! 9J_RH@[2V$?5VYZ&LH24SL$/W+:* !OP9D@(VR)P>& M4TRIN5>.&.@Y;]D"53\#120@9 ML(NK%]G[.G:!Z( E>/D!KURZEZ!0X4/(?)ULO2A_*\@,B=60Q/4C3!D+U3Z$ M?-?-UXOX]V@Y2#0#,B;YTK!Z#ZQ%H%:$D.R"V'MQ9,!B+N9\ZWYXGZ?Z;%WU M>>*<#FH*0MT)(0M^AA)>/#I/$JV>7/]GF/1R]NE"7W^\$?=\87EX;P5#'0@A0ZYA[%/_ M;):Z$;>"/Y)\[7V=":424"?"29S=W+V>#OGU N1<*)!0^<-)HJNY^I3]EDN% MZ-]D7G?)6HV'6A!..NWBW?0MT[P;F#LKMA5<>Q"HW"%DT)7LFE;8&"XPLG?N M7014WQ#2XBIN#)K:_!RPH# M$+?$JF%5OPJB= 1F,T#*UO>5+(\,+5"HVB$DI4ZV#2L_Y)3$1!$V^:@O105! MM%KV*AQ4\Q!24#O/A@6_%=@8C_7E?K::SNRN%3?CL6W4=N&A!H20@=;S]FO$ M0,H4B^?:45$*:DH(R2A4@Z8')1RG>HQ<]0Y']V8CN65(*J&@TH>0B-HX-BSU M)WXOD'F/Q7 U&W%JWRM4"80*'D+:Z6#:L.8[<52KO0>!ZAQ"OEG)SM, +J[=Q>P(:MR?/'+=#R$-M'#U)G:_]U^?;S8B2";+O M0706 ._!"L@ !_.F-X)FV\&VPK_2'ZI=L$"A^H>0O3K9-JU\FA"%DSRD*\(0 MBW5FM]D1:;F%4%\*ZD<(F2U4 R]/-[YB2C\POF!#C"1G.,E3#-<##FL1J"DA M9+L@]EX<^<)IJD43V=I=83E#+%"H R&DMDZV?I;+YJO4-_-6_D8]EP&V$E ? M0LAS(=P]+1I4V+RUC#SB=TBA=80N.VPEH':$D 5#N'O;+B'Z>M*:(THM4ZI"E M89?VE@)0#T+(F0',_7BQ?'J90;YSTFE$!1K\ HUP7+!R]O7>F#@V*U3RBP*6 M(&$QP86'VA!"_ES/NV$C;M04B^TKLRP8$[YK-4E]*:@I(2314 W\3--;;Y=P MSM([.*C\X:3+53S];*]+1Y3$5Y0C9SZP X/*'4YN7,'2B]H7B#V(=*[BU:W@ M,<;FZ9'+J^DD][ G%RL;K#8RS,@H][O%07NJ$']^46H#C4KA!2\&>K4N': M::=$4S?YH+]=?V-^F+_TH(_\ U!+ P04 " #MB?Q6[.C19#42 U8P M% '1M,C,Q-S8U,V0Y7S$P+3$N:'1M[5UM<]NX$?ZN&?T'U-=FDAG:EIW< M2VV?9QQ;Z;GCV!Y;=^E-IQ\@$I)P)@D>0%I6?WUWL8 (2O1+>D[EN+Z97/1" M @O@V;=GE\K>3X./)_O=SMY/_8,C^)OA?WN#X\%)?W]OD_Z&;S?=UWOOSXY^ M99>#7T_Z/ZZ-5%[NL*U>4;*!S(1AIV+*+E3&\X@^B-BET'*T!C?"K>?^OHSK ML#2WN[K!0WY3I/Y1@^TG(\*=?V]][O M]V\F"FW7L??S_L''_ND1_!FP;[;9X(P= MGIW^TK\8'+\_Z;/SB[./QY>79Q>_LM.S07]O\^?]KVFAOU6FE*.9^U#FBQO?RGQM?S"1AAUD(D_@3XF++Q4[5/FUT*4VWT9L M.&,\3]A0E%,A/LYY)/6"HS68(8J>1#F3JND;NQD!3+9:KMEX M%@JQ?.(CGLETMG/?A/9: T=$\JWM'_B#?_7-#]MO_[K[.'\MRQ?.Z>'3[11: M7$M5F70&NF@J!(YB!',X:%Z"_=,EAU,/E)TMZGK"47-.U;7(AD+3H;RSFKOM M 5-HF<>RX"GCF:H &Z#F?][:BGK;O:C7ZVWT>MW.:[RPQC@.W<"WVZ<7_#3/ M\HO@YT$P.J^TJ<#*=3O6/ 1HJ6U TT_< IV/7,<3.HRW/3+YH;4++0HB(G*0 ML.:F5&,!P-'6J($D#4L7L2:FYE^8IA'W"F%'=/#G>"TJA+=WZ)^21 L#3FJ: M"VTFLB"_0?;9*I!Y@6DK3 ]7!U,Z3W"K<+;S@[:>CH\A/D@B9JKA;R(NG9!I>,9NYYNM9X63T[-/ M,-1/_8O^A[.+?@3'K]E8J027W>U<\[3BJ/VPHT;"+EI](=W4(A829L/],=5H M)&,I\GB&_F$ZD?$$0T30;H$!8'R5JVDJDC&>F?4J',P*K,>>(P:/(Y5"C&%V MGL6F/I[R;:U.^2!INA QAJ4&,Z*-;J?/X53A>,,#Q!-&G:E/F'3.'JPAW^+0 M8H=B1I0(LG+"^!#BCI88%Z/G4E>D>3R.*T"=>P/?$*2Z'8A*7(0]3T'@BHPG M<*F5CB0-1WY6BOMX&-M>*<8.N0'G?\YGE&("T-#L8DC@+79MV>T1!\;=87'9 M3$.X$80&,> LAVBGB4P%*)D%03//P=%0B N8C$$L)GZO(.Z%2_Z\%?W0\_$N M@X@!K.10 (Q%D/)NN0!HHYZ9AV M$F$ P[<;*IAQ; 38$OIOA;D7=#A$RD PA, M'GY.R8"Q_E\@LR!'B%A:-*O7S#YPF5: :'$C3?D25;!]\85D<+9C,""PN' MA&36;1874.U81ARM<1'.DW)3@F;8D%1@[)+A>O K+?@()+Q;5=@"K>$VS6\3 M.X>C54DS'5UT*9XTJ3W)N]J/.#<3L10STU8U['8,A-QF),D/M*HCNYQ 8&1L MZ&Z]#"WS-2X96=);5]#D(#\H;66 F,I. )L6ZG^WXPP#+&((!D>(#&1ZL'01 MB69(U R4C!*Y(9+"B2B4L22N!4PJ./+*N!ZXF*=:.1(.8L]+2$YA$QRSQI)*>P5I1Q,*ZB6U%CXX#0OAQ=OL M13!1KCX+*](06>P4O:;V;-RSL$=##-_!S&LB&1'C,/ZH2D&)@GLM7(1+%#>QY8Q&;1-&+LUU>]=PJW00L^8QV,"@>0X;( #X;/AP[MY= MRCQ%^TJ'Q(LBE3'W,,"/!EJ.QW!Q?S1"]L.&M?G,?ZLLJZ9103%%JS,N$*=Y M%!:ZWB3CDN.TLB;M_KP284AB6K:^[2O?>T?$OS:KT>JD*N&2[*/W8ZT-5EBK;8=_A9T.E M =SSS]ZG/+YB6S"Y4:E,0(#E*C>&*O5"]S9ASI;IA^#*K];)Z>^ :4*90Y&^ M:Y$(Q?S<*8.-V<2=HYDG#VVQ7S5+6-/0>[)ZN,(M.[(@+4_247/[>D MUJCY=!U#H=8D:1[!U9:3R"[REMV.=:=^F-L-\;;+W:+:XRXPV\'<;H5/WZZL M!(G?K1B)6%N E?DH" 'UB6O-%#[06'UU.2 MMT&7-2CZ9X"[K<=%W6O^9F6PJWL")GA*%=B/8EX2Y14$JQ:,8J MNJ\0&D"562L9A/4NH_=\*N3V6#6&P Q!)7-K56U02;%QD.)!TNZ%P2X7!" * MJE7A),T%PI5K1";.A9&FPPYL,/"E2P$=T2=JEZ/OSM8RO1<'5*-,"CZ79L)LU&@$"&UM&B87YZ<.X$:P.Y M48IM42T7T15!M=KFYBR1)DZ5:;3I$&%50-JJ/>I<"K'8#>%&G=II%58T\ 6$ MOD;ED&'-4!1,O.*2)LA@&"U!P:CYCB>8=@I\1PDC3M6HBB-RG51A>7Q)#I=< MZX:;FWN,641J:4M]@7%8JO&]P+\-_O'JX-^_B4518I#@SQ_ THA7;PM&[B[] MYD+:2!H!)VY$7#DJ(6&)2#$);[.ON=)DO)TY=5T=Z DDB>VP\.Y((LX.R,% M\'> SL76DJ@,.)';Y,DP1WX[-:(L SQ8;LCG06X25[201G<@7Q=W8GUO"DH MM%'BVM8@0<=,Z5Q&!-X-IBS!9& >DOMW,(L&A47O4F$2';$A1[]2%>@S[*6A M*CJ PP6([PA]CPB5@Y0;LN#4EL4IC4$6EKH(R14KU#7[TO.SGCN,J"")+Z:P MS26_0C6'("Z3I?W4%H_&5=[TR'.KY;C2I;#Y@>/7PTLJ\VLB).Q:6>$:,F%6 M$F3&KJ4NJ\7(TII"D$2WE-5:%7^##?PZ2I)X1I681\08V*;/!AEM%GXSW[4% ML6BJ>P%L$Q([..&61J\[A8A)3R(;@4W RK@JDS/\2="MT9(8M_8RU8YL&1'8 MFN0"J9I>QBRFE&5ERY[!^)Y<0G>08'3Q]+_$PVGI[EYU9WLSL MX+B.=MMEO_"TPJ__-ZSV@LUO>U*IR5OW6N8DDBE8JU_E+AO,"ACZ0,-AQKOL ME&>"=@)2:%C?=H.^]G?A-R_4^E./2\0*DP(>3ZQ1;6NRKPE#^^F<,[16DL^= M4MB8!)%-2R'-5Q!]SLH0=_%$&.4ZQ&?%PV7,VP2Z.F; MN)4PZ-^OMA^4'D3I=@X:;M)1YVTMR'/MAI7@[0^/3[0QLO]K/.82(.82( MA+;![)(]SPU1@H)$3=(]9)#:Y0-1CBU#DI6"!6X(,?1 MCU(9E_.'B>M&P_;4+.1;FL=WUYVD['AN6J5@@2 )TC[;H0 ^EKQ:=!UPB-XM,)RWCQ5RWFNN_ MKM1R5+X,K--P?B"YY"6X"M! MS>X3E6+M!)0P+(1@OYXEHVU4BO$#/8VT5"\Q9!U\4\!BC2F0B\:*V,(T4:O M-E)!>DS-A(V>[[(J+8]=.8/9'F3#M[8E,N-7J%LH7")BJT)+E67T'K?2=BW> MLHZ@J%:F13IS7=]W%YM\%8#*:/A\L@@*65A%^ .'ZP]2Z<7M][S]!,WEDO%X MB?CN?ZJQM]H4@YA$C)K\HXT+/Y/B?#:Y6ZHE(1+S"D%CVZ2#(:)Y+.:KP\XU MN9"((RLM8CH-RP)(#/F& M=>O'WT#NT]@ %Q/F]9Q^/UCYDHG?I2>K??SW0Z4I.3HPIK)A;9B%6SPXL">J MT33D^7[_K @".?C>)A^VS1^&&=$D2-P;YX/P*7T*V6AT!QMJIG-A;ST @;LN M 4?VMRP@QXFI#Z[6(!I_7F*UD5_=+T_K0?>)91T,\PU59XM*%\I5/6YQMJCM598UFOOO*WE];P@+MBTKJ1A!CI?R_.I?>YO'3WB=#ZM O/W_*C:\?2DV/*82+3B7 MXU/VZ7APVK^\9)_P5SO./D1!-Q><,)H)9+^]KUUJX5K@YA=^C^$+_LC7X !_ M;.^P?W)R?G!T='SZMQ_7>FOV_>7YP:%_[_% :(]5FO+" "3\JUV(+I)R@@+U M_K)FCW5O<.%OLS]7%//4HYV@LN9/?W#4XIU#K^=%=@9V<%3?R0[/4-#3']>V MUYI;,X2,X0'[TQ89-'[MIG]ZU+_8"2>'_UT\B27^\=4M3_MD%E?_TM\CK+/Q MRX7^A_TBDJ+^]<*GM0%/YG3]A4[%OT4-_^_7^]GVRTW[]MY9W\]V[ISR;E]- MD?YGB?3N^[_4:UT!=#X;+H&L?V"4NP7^NYKD[.,&^/.1B/"Q**SJX6/M;2C< MM.['>J+G[(N>C"H_84?[_NSBXNS3BZO]VEWM@WZ5]VFM_\D<[HNGO=/3?@&Z M[XC?X[W M_WDYI_DM65*JQF\V+?Z8_.*/!#\+^NY=T$!\@K\H];5Q>*NCP#;QG[V@?P<# M_[F,_P!02P,$% @ [8G\5MWF,XIC&0 $8( !( !T;3(S,3P "9S*2V*B5L M 4Z,S=@F0'[][99LL,'.$Y*9/7O.S"184G>K7^INR>+HWY.!3AZ896NF\366 M2D@QP@S%5#6C]S4V)!,CL?CQ#B=,*U> M,K6_OY^<8)^8Z'0P">TG2U(J^>/RHJ7TV8#&-<-VJ*&PV2!=,^ZCX6/KK&O' MTK5 5WSB(4DGET!#JSH?X.^\EQ2-@:Y.:-==T=7QNFJVF9%3V:?H$#UF R91 M?5-(,\R0_3AN7LR[.^']YUV3CD4-NVM: ^J #!'2;ER2X_*>#TC<9DH $'Q. M],R'9^'DXNF4!V=).,&98G.'VC..JVR!W1Y.:( 1F0V:'DP+-26S&,7)<2OO8 MHI@CP[&FX7-U&P.H;,M9)@H>!CH9UF0^4?B04,P![R!EI6R,6R2C*OPD^-^1 MHSDZRQ\EQ4]H'3"'$AP>9[]&VL/76-$T'&8X\3;,(D84\>EKS&$3)RD,-XGC MDB[8H_^+QTE%8[IZ0%K,.20U.F '9*).#DFUQ'^YE>3B[57K+[ET4B@TX >2 M1^+QEXY.9V]QEK?N[&Z]V;T"1*8X&_66X;NE6P;:"*3#G[(!S)L6@2L6U:N& MRB;G;'HK@^V2W6;O0)45KYMU6_; M1_ M2FSH5#307?B@H=62'/QV3HHFNG#29H.A3AUF_^?+ER_0T*S7<6199X@??H/' M_RF9R@@_5HV9L5^ #Z@Z;& G *?]"NKVCD$!2K>I6]?-"3+AT6M@P S[U&+V MK7S+O;H 8O-GKX%30EH:+JST$DF1P#NF.B6V,]79UU@7[.* I*2A0]K: +K4 MV)@TS0$U=L2#'2# TKK< E7MP1NG:C9P?GI #--@O%&;'* I,0MME'_25)49 MW&+Q(W2L@1PL31'&.'&:Z <+=KV+FAR7LO G1@R8*8!GVD&H?L;R:ZRH<"3@6DA+O#6S(( @MFB!RX*!S9?[0$IX4OX09][?+3]N&>T MB8FMQMQF]+-?8[8&NLR$5W)1!8$+=+8YLCQLT(W+^,"=)M'4I6EZ'M/KRCA7 M9T]GSS456[H:LP@GGX4NG\7J>5 "BX/GZ)*A^%QL0^"IJ2Y3 3&,Y93 HO/S M*7B0YFU+PT!\$8.\ED6R @1X#UTV1O.V8IF#.8[Y;[?N@GQ;- <#TV@YIG)_ MR08=9GT:_^XA^.+.K5! ML_C4"A/-CN6]+DMS/DJ&@O>3E@RG[>^I--?4@E#4^=LH3&"^_U.6@Y&A"4V! M17M)_ -&[9'%\N[J?@!]/&!>4Q %0HN +T*%2!0N$WBG-^.8AR1+>"!\ +U; MYBV.YU>P8-%&L.@^I"6F&$.-.,YM,_S91%O&&"O/<"%)8:ZZ[YO ME1=!AQ=9'25A//S$_X^&7C0VH%9/,PZ(%,O_ZQ^I/>GP*#G,1W:9-?JBS.9( M9_$&[?%0W1_HB7%QQQP>D/000E'W0<=T''/@/AMKJM/',%+Z*Q88W3$MH%N, M/M:II!$>VK>CK%IW-8>(?*%I_.I(0?]P!8-!5.B1H['&J:SUXI("C0O]^U,E?U:KM-6LMJOE%BG42J3\HWA:J)V42;%^>5EMM:KUV@NH>399>"DUUX76 M:;5VTJ[7=D@I44P06=K-[",%:\;]4>RNU)N7+BY[2 WN(#%WVX?5'Q/F>-Q+ M3K%*<:O,F5S MHWU:_DCB?.8_,_U"L4WJ%9+:3V?^6Q0 XS%B=DF3#4W+(5O>9T9AK66V0]@# M]-S$!7%N%>N*TRIU%J./>EW/[^JVQ5%*:^QK2) M M9F.)W\':6;BXRC_8HU)-5^KGF3>ZUC!:K?*$*@ZG'"W!FE%,J$WL(5,P&52)!@QU;*) K O#ME=&U))N.+2C M,Z!.UX$#"M]\DV+\\Y"JJO?YU4A]@>@LOE1,7:=#&Z)([S>1F1PY7G!^Y*@+ M :L7DW868U*7.IA60M[%F7D_=C$.?F"6HRE4][@/<>^,IK3\5Z1"+ZIR(:#* M54,Q+?!4O'3-\^NBV&4IFFJ$9F?:-_6KZMGYC7;W5D>$6VB8$3ML:)D/J#A! M3_0"VL 3,YV.P8<]J?B.NBR'"#ZG$ME01@MYS>7_UUSAPJ"O4NYS5' \6AE+Q="XMR7\?^41:(1>.AQ_P]2Q0 M9!6]AVD=D'%?PW4V1(J[ 2FVZ:3JUM84;A-/B?3RNG=?RK:->%+#[*T@"_K&BG>,"VR,X';K\<-= 3(N83I]9Y&YD:;:J*4CL M4P=,\%RMV;;/L+1HHA@^6]*^3G/,\NUL9<;.N(\6"VK_!:F8#7 M*JBJQ6S;_8&[XZEPCR45B_95?6]@GM%W>:P0A+%\2I92I Y!:8^1EF,QYD1X MK1V7C4]&3A4^ +4-UJ M0"P+JTQ$V*Q!C&6PJU\/@]C9>]ERHT)D_*#(+]8X+J#/[JP[- MCSFDH:U@*$%NJ<- MJ4[8A"DC1WO $@%$!LE&UFK+.-N+2JZY"HZ.LZ" MQ6BT:G\_J7RW]/[@ZNRMJNW'$\LN>.5Z8(.5&WS2>S'/IR\-=]=Q!/+R[N9^%XJ'44R"?K7=9;CYB7#?_TC)Z>RAS;TT]D0J24& M)W<'TR%]A$:RN0%K H5IZF@YF1#0;;,IAA@KR=$P0 MZ6"D.]1@YLC6I\2&--CN3OEX=X#9 ?0B.S8%8%_E'&(0U!5CZK5U(;LTQS@. M8S\-:P3VP;H9$IE6^]/HQ33[?6FU_TR(%'(F1,+3&A"Q>&A"5G9^9'@>#+C@ MN?[@DK[< D&"9BS$@OR 2)<.-'UZ\-SQY>B!U\ 49)0=BTR&KBW- ;7!TL_( M<,LE=OBRU<]6S\WTQ?0QDWKS%F#'-'5X.V;^@A9(A-"!W&!E1!G\$N1NJ M42X:(->/APQ'ECU"O0?+P;,V)"/ONC: RM^"V!$&:B"$@N*0K526%"M- GQ) M0,= J/:[J8;+F[=HB!?3M$Q^>!$Z78(_ J>DAZN'SH@YI5QT:%D,K MQ;/[_.0-+CE6O=N-"G9'[4;;:-9ZN]>=E:M%-"VK=QV *Z[XD#WK0U(9-2YO M=;9?IC.B[V^M->_P)?OARE.U[1&SGE6AZH]OI?WT>5?:?5UI]@TJM$31"OW, MZS4HS>*9+>5E&N3V]6G0O&CP9Y]Y\BV_(D1E%@2Y?FY!#V2A>QH-#4G\:G8W M-Y!KP*S/"U8_;T7[."J!LLNZ4N[Z&E]?K.\F.==7U/ M(Q+D-K[Y*DZU*7VBX-L6T=OU7HEU!02]KS[L$B+OKY4U%L7.I#4==$Q]"\N8 MSS!&_ET8DUX%)=%%%??X%U<9YGE)2&['?4WI>]O"<_\QXYN_#OW,Z MPK^\$KI.;9J2.US=0U<^[STJZ![U[I&OS]+;:K>/>BY3NBEG"YUV]\F5\PUO M__FC\X6YQ/*B.^']=T"0%GF@^HB1?TH)24J1(;[9U7_J\-2+RNI/K4AO!A"5 M!KF6)PQO/=)J:S^'6JE<>C34-4HK,!%^HK/Q!XBAN& W7B 4>03VW=(H3K/V MC:GMG0Q6+XW%755T6,L;JF%SC>7;$-#4J*W27\*^R"6U[IE#+BZ*3\DQS,]% M[CBN<$LKZBC#&AQ@X.U+$.#QP#C^<9\^1C5_CP"#;[$^Z?CX0/E=X_OL[L4B6+DQ[JW))RX(L"#_&-S[? \^K%J6Y,I9NN=;]2GG^JQUO7[GE4\K=:+!C_QO)50\5* 2.= M*5'X3A$,N0>'S?BQT^ &SN:&9A/0(A ^@NT1\/)CIX\5AR'NZE";J*RK&>*] M""PVB!EDI%UOQV>AZ U/4_OI--G"CME#7OOV.FO\M8HAOE:!.XUS<. 7XS(_ M_KH ,5#&$* S,]!8S<"!2\ 3'YS#OW_+L!S.?_];/J^LI 5/ GKP3SCXHH > M7D1KGO8KO9OCBZMO>NQ9I*NML3U!ZTO+:^MZ66* V9JF+S2-8)P GL!4G>O%Z]ZT_@VKKB6 27"D>E3Q#[6 #>: MO 'S@1:+/6@VC /CIX:"6QU4X3>;\;,8>-&>2BW5%MN\ZI-UMO06G=79EHJ3 M"=%"7J'DSW3R%.7/4(Q/OHO 5WX)/=[BNZM@=7<1_-Z\1YH/H?^O$1;@ :R8 M _1EGD9>1K(+ZF4'"*J/7Y$8/D.!C]OAWGOMHLE]!:C]_$. RL&&H><9C_* MO1",2,9K4?I%^MM+LY/'*^U(*B&E$J2,[^#A81>34.)M!Y,2AC,:/^%9Z%F, M1[V)-1QZ6]<* JL",WB9D^_2U0WB?_%YA_ 7;R&''%"%C7C:!_"JAI+8W-A" MWXMG[63IL.@%&/ I=;A->$[!HSQ@U^PR./(/&=UYT31X#HD[%0V(YS7;-H&U M-1,6)S]0]!W^.JRN2'>:@Z8#I"(=:@[5=S \#X+Q=_-@)$C# MM\"X86( VPY_6O0B5V@*XJ,H;G5S X9W1Q8/ABF.Y<.@U\ 6@21U(,6R'*KA M\8_YQ(?SB1LX<7Q)704>/(A[H#)< #*&R0C/M#00'1X0F!TMI@-*&3MG'NPO'-* 1_$ G/I/",:02'D0$J?I"6A(&2+VIL; M+C3!,1>W'V4"-(:O]Y:*%^J*X.#M/$="9ZS&XKK*!D,1BLP.B7GI!)+!T0\I M5BU&.K46D,Q #NET$9WA<1F%1^T^ 2\.[(3._TSMY"3!<=. 5,,BPG<*\TE) MGOWP;0 /RA@X/Z2:BOL#@7Z"09"DXRQV !2(S>"GY0RR #J=\D 'VC@G^$E* ME4YG&Q+\U@."419Z*D6HE@.Q^BY; 0P<8I0$^J*A*A,!X=K3<6-%)[T-S>$ M]J+\B;@P"]5SEG&B.JF:K8QL#$3YV4;03% 05$<>@2+'Q:E#B(9-^+2S,,,! MS!D\H$GL46>@.; 06+BN ]=A2$ 3@;+1D"LJ"+8'.M9S;\P Q9%<\/2N.V_4O&4JN".$I!H3BA<*E"S+$P!@_X'+HYD/%+KE M5](Q"&QSH\.XA#1K;N(1$UQT140=69X^A!M'@K1YWN27.>\=%.#FQA*WD08V M4=RW1?P8W';4,R#]23YY[@+L["F6K;QXL1 Q?$A84GI.%@$'Q:M08%P#/'0Y MDSMV6-9[;X'%>@)RU;W6%S5*%,QM7OESQ>0IUU:X+2TQW[.JS0T(G'#Q07I, M@;%#;6TF_W @#4L#%=T*5LT\ ]SFNFN.\.Q\#W)G+XYA$]QJ1MTV>4&@#.KO M3!<!=8KRM4TT<6F/ E.#IS9L,^(AH6&VC Y2=PPQ* !1K-&#'NYX:0^7LT M+//YOT(-V_ZU ?AB*Y86,/U%)[*YH9I,^+SAR.)7)P&'P+)YH036%;XH@1K@ M68&&JD)=2^!?[3YB5J(C%PM!XY#JN"^B$#1#KC.JN3" M[)\\"UX _M2!VA(4' M8B@R=H^R@T[/[SGP^T,AC5D\T84L0OB-\)T4++^+<;S=%X?PWHEN=B!8N5QA3 MP@1VELRN]O55<2#71KCJ,&?-] =R5PH(;U?VF[^Y!X)9>3H)D0&?HRKG% M[*!O%RGP&35&%*)G6>9>+H/I$X^>-$@>%QT)#S;1('FF MOWSL !A#!I!!(A$8\L,,%MW W%&(68B-2_ZV4(03P"H0^@]S:4;_Q>ZA&@S! M9X%5A/S<:)7JNLFS@&5E<761&[FK7GQ54]ALQ5D2:D1ZP&%@PC;JW(%OXD5! M=1:+8(R'&=W0Q"_, 7;'?&U69[5_.#KG87,!NE&TG M A=.>"\"?ZC(M!F?M36'K)$$;*G;,XY\(ADA?%C_"Q*O?PMBZ:ZBT*/M_"Z^ M=5T.X K+.[".-Y>%7XKS&]!:FB?> 1J?OMIEP9HCH%,BOEK(&"K1=P;/.17,KV>63R..4X:>GGR2MGG6^Q[BENJ;3^_V[+C;/<'=P([8 ME.DP9XQ!6:TY"=\<7-JZF>_/8GO=YPL_Z2R$?$CJ MW([M X3KGO,Y%#DY-'_,48FP"]Z69/^RH"/P+7-BEH<$OR7@@!0LVM$4[XOG MD!,U$^*.PY7^G-E9Y47_UI%9H7S7+GW]K^P?EVN)4WRQWM5]Z(-9_ M0& G[&R@BFL"+X*IHGPB+N]Q2]LV4"G2&JQC=UB?ZEVOBLV+(Z+#Y@8F-B,\ M'\+AT9'3-RTP./5W*(^\ZLZ7R/=AWQD6!F??,77U12S@TYM]%>\!&0TAX57P M:W6??$E@55B"U[-&GA]Z\4N0S[#E)5^T^?RT7PGE@^C&;Z(X<*]06_Y7%.QS MWE=4O. 5V3=?,1;+DZ2=A(B.#?L0]UU#1$9W8V2=U?57Z-'PO?FE=?OM7'T\'TRW&UW^]H/ZX? MZ-69*9WU]*&3,1\[]TW[KFF<=8SZ?=HZGQJU@GVME;^-^*_0DUSO6=X_O M4H\GN5'6N/Y2EJYV.^ESI;=[U;P\D^Z+WWYUSBJ-LTJM;F5/;O16=K^]W.Y5[I(:[*)M7APW?\@ML]&[MBXZ%]]O+B;*1;4CUZ;-XMG#\;G1->\; M^J^?C]F:62OL&I5+^:?\BZ8IE>].^AG+NI!_G*JE[LE>]>IGZV;_:G_R<'/' MKIS46-$OK_5Q]_OQ96OWXD&NU&Y&,+'BWCBM5;+MJE4^R_:2DZSQ+5/0Z.5X M_[Y\,GTH5-I%LU YWBTDL^<91\E]O_E^\7/XLWAV?]>?E))?*GO6W:]*LU21 M&^-[N6!V3[OER9ER>IHK7-ZQZ\+XZU' M,C R,S W,#'-D M4$L! A0#% @ [8G\5I04 <+," H6D !4 ( !; , M &YR>' M,C R,S W,#=?9&5F+GAM;%!+ 0(4 Q0 ( .V)_%8<5#IFI L M &B/ 5 " 6L, !N&UL4$L! A0#% @ [8G\5NSHT60U$@ M-6, !0 ( !F" '1M,C,Q-S8U,V0Y7S$P+3$N:'1M4$L! M A0#% @ [8G\5MWF,XIC&0 $8( !( ( !_S( '1M F,C,Q-S8U,V0Y7SAK+FAT;5!+!08 !@ & (H! "23 ! end